Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
Notice Shareholders of Boston Scientific (NYSE: BSX): Corcept Therapeutics (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR); and Unicycive (NASDAQ: UNCY)
-
LOS ANGELES, March 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Boston Scientific Corporation, (“Boston Scientific” or the "Company") (NYSE: BSX) investors off a class action on behalf...
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options If you...
-
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Boston Scientific Corporation, (“Boston Scientific" or the "Company") (NYSE:BSX) investors that the firm has initiated an...
-
We have renewed our investigation into the fairness of the proposed sale of Silk Road Medical to Boston Scientific for $27.50 per share.
-
We are investigating the fairness of the proposed sale of Silk Road Medical to Boston Scientific for $27.50 per share in cash
-
We are investigating the fairness of the $71.00 per share in cash pursuant to which Axonics, Inc. has agreed to be sold to Boston Scientific